Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645918 · ClinicalTrials.gov registry record · NA
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
A NA study of Acute Coronary Syndrome and Coronary Arteriosclerosis, sponsored by Accumetrics.
- Completed
- Registry status
- NA
- Development phase
- 2,800
- Enrollment target
- 20
- Study locations
NCT00645918 is a NA study of Acute Coronary Syndrome and Coronary Arteriosclerosis that has completed, run by Accumetrics. The registered enrollment target is 2,800 participants, roughly in line with the 2,652-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target. The trial reports 20 study locations across 7 states.
The verdict
NCT00645918, a NA study of Acute Coronary Syndrome and Coronary Arteriosclerosis, has completed, sponsored by Accumetrics.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,800 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the GRAVITAS trial is to determine whether tailored anti-platelet therapy using the Accumetrics VerifyNow P2Y12 assay reduces major adverse cardiovascular events after drug-eluting stent implantation.
Conditions Studied
Interventions
- DRUG placebo
- DRUG clopidogrel
Study Locations (20)
California
- Scripps Green Hospital - La Jolla
- El Camino Hospital - Mountain View
- UC Davis Medical Center - Sacramento
- Sacramento Heart and Vascular Research Center - Sacramento
- UCSD Medical Center - San Diego
- Alvarado Hospital - San Diego
- San Francisco General Hospital - San Francisco
- UCSF Moffitt-Long Hospital - San Francisco
- Santa Barbara Cottage Hospital - Santa Barbara
- Torrance Memorial Medical Center - Torrance
Florida
- Clearwater Cardiovascular and Interventional Consultants - Clearwater
- University of Florida Health Science Center - Jacksonville
- Cardiology Research Associates - Ormond Beach
Arizona
- Scottsdale Health Care - Osborn Campus - Scottsdale
- Scottsdale Health Care - Shea Campus - Scottsdale
Connecticut
- Bridgeport Hospital - Bridgeport
- Danbury Hospital - Danbury
Alabama
- University of Alabama at Birmingham - Birmingham
Delaware
- Christiana Care Hospital - Newark
District of Columbia
- Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,800 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00645918
The ClinicalTrials.gov registry entry for NCT00645918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,800 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,652-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target. The listed sponsor is Accumetrics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00645918 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT00645918 about?
NCT00645918 is a clinical study titled "GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety". The objective of the GRAVITAS trial is to determine whether tailored anti-platelet therapy using the Accumetrics VerifyNow P2Y12 assay reduces major adverse cardiovascular events after drug-eluting stent implantation.
What is the current status of trial NCT00645918?
This trial is currently completed. It is a NA study. The enrollment target is 2,800 participants. The study started on 2008-06. Estimated completion is 2010-10.
What conditions does trial NCT00645918 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Coronary Arteriosclerosis.
What interventions are being tested in trial NCT00645918?
The interventions under investigation include: placebo (DRUG), clopidogrel (DRUG).
Who is sponsoring clinical trial NCT00645918?
This trial is sponsored by Accumetrics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00645918 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Healthy Heart Habits-2
ACTIVE NOT RECRUITING · NA
-
LEADERS FREE II: BioFreedom™ Pivotal Study
ACTIVE NOT RECRUITING · NA
-
OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study
ACTIVE NOT RECRUITING · NA
-
Post Acute Cardiac Event Smoking (PACES) Study
ACTIVE NOT RECRUITING · NA
-
Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.